The New York Stem Cell Foundation and the Stanley Center at the Broad Institute of MIT and Harvard are partnering to create a foundational stem cell resource to study psychiatric disorders through the production of induced pluripotent stem cell lines from individuals with schizophrenia and other psychiatric disorders. This new partnership aligns NYSCF's mission to accelerate cures for the major disease of our time through stem cell research with the Stanley Center's goal to reduce the burden of serious mental illness through research.
http://ift.tt/1FBXUN5
http://ift.tt/1FBXUN5
No comments:
Post a Comment